CLINIPRIME
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97533508
- Registration number
- 7271459
- Mark type
- Stylized text
- Filed
- 03 Aug 2022
- Published for opposition
- 01 Nov 2022
- Registered
- 09 Jan 2024
- Attorney of record
- Joseph V. Myers III
Goods and services
- Class 001 — Chemicals: Biological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical research; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells for research purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissue, namely, blood for scientific or medical research use
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes
Owner
- Charles River Laboratories, Inc., Wilmington, MA, US
- Charles River Laboratories, Inc., Wilmington, MA, US
- Charles River Laboratories, Inc., Wilmington, MA, US
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Aug 2023 — NON-FINAL ACTION E-MAILED
- 12 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 23 May 2023 — DIVISIONAL REQUEST RECEIVED
- 12 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jun 2023 — USE AMENDMENT FILED
- 12 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jun 2023 — TEAS STATEMENT OF USE RECEIVED